Cargando…

Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

BACKGROUND: The rapid spread of the 2009 H1N1 pandemic influenza virus (pH1N1) highlighted problems associated with relying on strain-matched vaccines. A lengthy process of strain identification, manufacture, and testing is required for current strain-matched vaccines and delays vaccine availability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soboleski, Mark R., Gabbard, Jon D., Price, Graeme E., Misplon, Julia A., Lo, Chia-Yun, Perez, Daniel R., Ye, Jianqiang, Tompkins, S. Mark, Epstein, Suzanne L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137593/ https://www.ncbi.nlm.nih.gov/pubmed/21789196 http://dx.doi.org/10.1371/journal.pone.0021937

Ejemplares similares

Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus
por: Vitelli, Alessandra, et al.
Publicado: (2013)

Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
por: Price, Graeme E., et al.
Publicado: (2010)

Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice
por: García, Mayra, et al.
Publicado: (2016)

Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model
por: Dhakal, Santosh, et al.
Publicado: (2021)

The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice
por: Rowell, Janelle, et al.
Publicado: (2019)

Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1
por: Tompkins, Stephen Mark, et al.
Publicado: (2007)

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
por: Epstein, Suzanne L., et al.
Publicado: (2002)

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021)

Cold Agglutinin Disease
por: Gabbard, Amy P., et al.
Publicado: (2020)

Complement activation by recombinant adenoviruses
por: Cichon, G, et al.
Publicado: (2002)

Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic
por: Lo, Chia-Yun, et al.
Publicado: (2017)

A novel recombinant serotype 4 fowl adenovirus expressing fiber-2 protein of duck adenovirus 3
por: Guo, Yiwen, et al.
Publicado: (2023)

Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity
por: McMaster, Sean R., et al.
Publicado: (2015)

Effect of cold atmospheric plasma (CAP) on human adenoviruses is adenovirus type-dependent
por: Bunz, Oskar, et al.
Publicado: (2018)

Genome Analysis of A Novel Recombinant Human Adenovirus Type 1 in China
por: Zhang, Wanju, et al.
Publicado: (2019)

Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin
por: Alexander, Jeff, et al.
Publicado: (2012)

A Novel Fiber-1-Edited and Highly Attenuated Recombinant Serotype 4 Fowl Adenovirus Confers Efficient Protection Against Lethal Challenge
por: Mu, Yaru, et al.
Publicado: (2021)

Efficacy of a Parainfluenza Virus 5 (PIV5)-Based H7N9 Vaccine in Mice and Guinea Pigs: Antibody Titer towards HA Was Not a Good Indicator for Protection
por: Li, Zhuo, et al.
Publicado: (2015)

A simple system for rapid generation of recombinant adenoviruses by ligation
por: Dudler, J, et al.
Publicado: (2002)

Fiber-1 of serotype 4 fowl adenovirus mediates superinfection resistance against serotype 8b fowl adenovirus
por: Lu, Hao, et al.
Publicado: (2022)

Dose Effects of Recombinant Adenovirus Immunization in Rodents
por: Weaver, Eric A.
Publicado: (2019)

The Change of Immunoactivity of Dendritic Cells Induced by Mouse 4-1BBL Recombinant Adenovirus
por: Youlin, Kuang, et al.
Publicado: (2010)

Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
por: Li, Li-xia, et al.
Publicado: (2013)

Polymerase Discordance in Novel Swine Influenza H3N2v Constellations Is Tolerated in Swine but Not Human Respiratory Epithelial Cells
por: Powell, Joshua D., et al.
Publicado: (2014)

A novel and simple method for construction of recombinant adenoviruses
por: Tan, Rong, et al.
Publicado: (2006)

Bacterial Biowarfare Agents
por: Soboleski, Mark, et al.
Publicado: (2006)

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
por: Infante, Jeffrey R, et al.
Publicado: (2018)

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
por: Infante, Jeffrey R, et al.
Publicado: (2018)

Observations on the Fine Structure of Type 5 Adenovirus
por: Epstein, M. A.
Publicado: (1959)

Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines
por: Lin, Shih-Chang, et al.
Publicado: (2011)

Analgesic and side effects of intravenous recombinant Phα1β
por: Rigo, Flavia Karine, et al.
Publicado: (2020)

Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot
por: Oronsky, Bryan, et al.
Publicado: (2022)

Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1
por: Zhou, Shi-you, et al.
Publicado: (2010)

Effect of human interferon-λ1 recombinant adenovirus on a gastric cancer orthotopic transplantation model
por: BU, XU-FENG, et al.
Publicado: (2014)

Whole genomic analysis of a potential recombinant human adenovirus type 1 in Qinghai plateau, China
por: Yu, Juan, et al.
Publicado: (2020)

Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”
por: Yan, Yuqian, et al.
Publicado: (2020)

Production of Recombinant Adenovirus Containing Human Interlukin-4 Gene
por: Mojarrad, Majid, et al.
Publicado: (2011)

AdenoBuilder: A platform for the modular assembly of recombinant adenoviruses
por: Jang, Yumi, et al.
Publicado: (2022)

Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury
por: Sosnovtseva, Anastasiia O., et al.
Publicado: (2022)

Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus
por: Cao, Liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r8mtfkj2v388594mqc2k136vps